Xanthine compounds and method of treating bronchospastic and...

Details Xanthine compounds and method of treating bronchospastic and... Xanthine compounds and method of treating bronchospastic and...

C - Chemistry, Metallurgy

07

D

260/242.4

C07D 473/06 (2006.01) C07D 239/545 (2006.01)

Patent

CA 1077932

ABSTRACT OF THE DISCLOSURE: Bronchial asthma and other bronchospastic and allergic diseases are treated by administering an effective amount of a substituted xanthine compound having the formula: Image wherein: R1 = C1-C2 alkyl, R3 = -CH2-(C3-C4) alkyl, -CH2-(C3-C4 cycloalkyl) R7 = H, COOR R8 = H, C1-C4 alkyl R = C1-C4 alkyl, 2-halo-C3-C3 alkyl, or phenyl Provided: R7 AND R8 are not H simultaneously. The bronchodilator and antiallergy agents may be administered the form of tablets, capsules, aerosols, solutions, suspensions or suppositories.

274520

Affiliated with

Also associated with

Rating

Xanthine compounds and method of treating bronchospastic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthine compounds and method of treating bronchospastic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine compounds and method of treating bronchospastic and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-499826